These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6877803)

  • 21. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy].
    Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Kuhn H; Boch H; Lösse B
    Z Kardiol; 1981 Jul; 70(7):501-7. PubMed ID: 7269730
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prazosin in chronic refractory cardiac insufficiency: results of continuous long-term therapy].
    Sánchez Domínguez J; Villa JG; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Apr; 161(2):113-7. PubMed ID: 7280315
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
    Szmydt W; Kaftańska A; Paradowski S
    Pol Tyg Lek; 1984 Nov; 39(46):1509-12. PubMed ID: 6393093
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of prazosin in heart failure using exercise tests: short- and long-term results].
    Sánchez Domínguez J; Barciela Vilas R; Largo Aguado F; Urbina Fuentes FJ; González Villa J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):17-21. PubMed ID: 6635272
    [No Abstract]   [Full Text] [Related]  

  • 27. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 28. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prazosin in refractory congestive heart failure].
    Timio M; Gentili S; Pede S; Schiaroli M
    Boll Soc Ital Cardiol; 1978; 23(4):768-76. PubMed ID: 757362
    [No Abstract]   [Full Text] [Related]  

  • 30. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute and chronic treatment of chronic cardiac insufficiency with nitrates or prazosin respectively].
    Bussmann WD
    Ther Umsch; 1981; 38 Suppl():49-54. PubMed ID: 7339917
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prazosin in arterial hypertension with cardiac insufficiency].
    Antani JA
    Cardiology; 1980; 66 Suppl 2():132-7. PubMed ID: 6456812
    [No Abstract]   [Full Text] [Related]  

  • 33. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR; Miles D; Mehta J
    Cardiology; 1980; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract]   [Full Text] [Related]  

  • 34. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 35. [Haemodynamic effects and plasma concentrations of prazosin in chronic heart failure (author's transl)].
    Pornin M; Decourt S; Sellier P; Guermonprez JL; Ourbak P; Maurice P; Flouvat B
    Therapie; 1981; 36(4):435-42. PubMed ID: 7292426
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prazosin--a new hypotensive agent].
    Kocemba J; Kawecka-Jaszcz K; Sniezek M; Augustyński W; Starzycka M
    Kardiol Pol; 1977; 20(5):381-7. PubMed ID: 926531
    [No Abstract]   [Full Text] [Related]  

  • 38. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
    Franchi F; Michelucci A; Morace G; Porciani MC; Fantini F
    Clin Ter; 1980 Apr; 93(1):3-20. PubMed ID: 7449331
    [No Abstract]   [Full Text] [Related]  

  • 40. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.